Novavax Inc (NVAX)
138.79
+1.93 +1.41%
NASDAQ
Oct 21, 16:00
138.80
+0.01 +0.01%
Pre-Market: 08:25
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 1.182B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -13.71 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -949.91M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -118.2% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 10.34B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 8.058 |
| PE Ratio | -- |
| Price to Book Value | 13.87 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.4329 |
| Free Cash Flow (Quarterly) | 129.26M |
| Return on Equity | Upgrade |
View All NVAX News
News
-
WireHeadlineTime (ET)
-
Yahoo10/22 06:30
-
Yahoo10/22 06:05
-
Yahoo10/22 05:52
-
Yahoo10/22 05:51
-
Yahoo10/21 21:26
-
Yahoo10/21 19:25
-
Yahoo10/21 18:01
-
Yahoo10/21 17:47
-
Yahoo10/21 17:45
-
MT Newswires10/21 17:18
-
Yahoo10/21 16:03
-
Yahoo10/21 15:09
-
MT Newswires10/21 14:40
-
Yahoo10/21 12:55
-
Yahoo10/21 12:21
-
Yahoo10/21 11:57
-
Yahoo10/21 10:30
-
Yahoo10/21 10:20
-
PR Newswire10/21 09:31
-
Yahoo10/21 09:19
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 11/04/2021 | Earnings Results | Q3 2021 Earnings Results |
| 11/04/2021 16:30 EST | Earnings Calls | Q3 2021 Earnings Call |
| 08/05/2021 | Earnings Results | Q2 2021 Earnings Results |
| 08/05/2021 16:30 EST | Earnings Calls | Q2 2021 Earnings Call |
| 06/17/2021 | AGM | 2020 Annual General Meeting |
| 05/10/2021 | Earnings Results | Q1 2021 Earnings Results |
| 05/10/2021 16:30 EST | Earnings Calls | Q1 2021 Earnings Call |
| 03/01/2021 | Earnings Results | Q4 2020 Earnings Results |
| 03/01/2021 16:30 EST | Earnings Calls | Q4 2020 Earnings Call |
| 11/09/2020 | Earnings Results | Q3 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.
- URL: https://www.novavax.com
- Investor Relations URL: https://ir.novavax.com/
- HQ State/Province: Maryland
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Nov. 04, 2021
- Last Earnings Release: Aug. 05, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 138.79 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| FRBRX | Franklin Biotechnology Discovery R6 | 3.04% |
| BBH | VanEck Biotech ETF | 2.61% |
| FIJYX | Fidelity Advisor® Biotechnology Z | 1.75% |
| HQL | Tekla Life Sciences Investors | 1.26% |
| HQH | Tekla Healthcare Investors | 1.02% |
| IBB | iShares Biotechnology ETF | 0.81% |
| VISVX | Vanguard Small Cap Value Index Inv | 0.49% |
| VBR | Vanguard Small-Cap Value ETF | 0.49% |
| FZFLX | Fidelity® SAI Small-Mid Cap 500 Index | 0.46% |
| LBNQX | Lord Abbett Bond-Debenture R2 | 0.37% |
| NAESX | Vanguard Small Cap Index Inv | 0.32% |
| VB | Vanguard Small-Cap ETF | 0.32% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NVAX Tweets Stocktwits
Advertisement
